XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Financial instruments (Tables)
6 Months Ended
Feb. 28, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Notional Amounts, Fair Value and Balance Sheet Presentation of Derivative Instruments Outstanding
The notional amounts and fair value of derivative instruments outstanding were as follows (in millions):

February 28, 2025Notional Fair
Value
Location in Consolidated Condensed Balance Sheets
Derivatives designated as hedges:
Foreign currency forwards$281 $Other current assets
Cross currency interest rate swaps50 Other current assets
Cross currency interest rate swaps250 Other non-current assets
Foreign currency forwards950 Accrued expenses and other liabilities
Foreign currency forwards— Other non-current liabilities
Derivatives not designated as hedges:
Foreign currency forwards$455 $Other current assets
Total return swaps53 — Other current assets
Total return swaps158 Accrued expenses and other liabilities
Foreign currency forwards3,205 15 Accrued expenses and other liabilities
Variable prepaid forward contracts2,190 2,498 Accrued expenses and other liabilities
Variable prepaid forward contracts 106 112 Other non-current liabilities
August 31, 2024NotionalFair
Value
Location in Consolidated Condensed Balance Sheets
Derivatives designated as hedges:
Cross currency interest rate swaps$50 $Other current assets
Foreign currency forwards7— Other current assets
Cross currency interest rate swaps253 Other non-current assets
Foreign currency forwards— Other non-current assets
Foreign currency forwards923 15 Accrued expenses and other liabilities
Cross currency interest rate swaps356 Accrued expenses and other liabilities
Foreign currency forwards— Other non-current liabilities
Derivatives not designated as hedges:
Foreign currency forwards$534 $Other current assets
Total return swaps211 11 Other current assets
Foreign currency forwards3,606 52 Accrued expenses and other liabilities
Variable prepaid forward contracts1,185 1,332 Accrued expenses and other liabilities
Variable prepaid forward contracts 2,541 2,587 Other non-current liabilities
Schedule of Derivative Instruments
The terms of the VPF derivative contracts were as follows (in millions):
Transaction datePrepayment amountRemaining shares pledged and maximum shares subject to forward sale as of February 28, 2025Forward settlement date
May 11, 2023$644 4.6Fourth quarter, fiscal 2025
June 15, 20233252.2Third quarter, fiscal 2025
August 3, 20238015.3First quarter, fiscal 2026
August 4, 2023797— 
Third quarter, fiscal 2026 1
November 9, 20234240.5
Fourth quarter, fiscal 2026 1
$2,991 12.6
1.During the three months ended February 28, 2025, the Company early settled certain VPF derivative contracts. These contracts, originally scheduled to mature in the third and fourth quarter of fiscal 2026, were net share settled early through the delivery of an aggregate 6.1 million shares of Cencora common stock to financial institutions, with the Company retaining 1.3 million unencumbered shares. As part of the settlement, the Company paid an aggregate cash payment of $20 million to fulfill its obligations under the contracts. The Company recognized a gain of $955 million within Other income (expense), net as a result of the settlement.
Gains and (Losses) due to Changes in Fair Value Recognized in Earnings
The income (expense) due to changes in fair value of derivative instruments was recognized in the Consolidated Condensed Statements of Earnings as follows (in millions):
  Three months endedSix months ended
 
Location in Consolidated Condensed Statements of Earnings 1
February 28, 2025February 29, 2024February 28, 2025February 29, 2024
Total return swapSelling, general and administrative expenses$(7)$18 $$17 
Foreign currency forwards
Other income (expense), net
(7)(26)84 33 
Variable prepaid forward 2
Other income (expense), net
977 (522)777 (888)

1.Excludes remeasurement gains and losses on economically hedged assets and liabilities.
2.Includes $955 million settlement gain in the three and six months ended February 28, 2025.